The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity. - Mukhopadhyay, Partha; Baggelaar, Marc; Erdelyi, Katalin; Cao, Zongxian; Cinar, Resat; Fezza, Filomena; Ignatowska ‐ Janlowska, Bogna; Wilkerson, Jenny; Gils, Noortje; Hansen, Thomas; Ruben, Marc; Soethoudt, Marjolein; et al. (British Journal of Pharmacology, 2016)